Antigua and Barbuda vs South Africa: Immunization, measles second dose
Antigua and Barbuda
82.0%
in 2024
South Africa
82.0%
in 2024
Antigua and Barbuda rank
98th
South Africa rank
98th
Immunization, measles second dose over time
- Antigua and Barbuda
- South Africa
How they compare
Antigua and Barbuda currently reports 82.0% against 82.0% in South Africa, a difference of 0.0%.
The two have swapped places 8 times across 20 shared years of data; in 2005 it was South Africa ahead.
Antigua and Barbuda ranks 98th and South Africa ranks 98th of 178 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.8% | 53.4% | 20.4% | Antigua and Barbuda |
| 2010s | 87.0% | 62.7% | 24.3% | Antigua and Barbuda |
| 2020s | 83.2% | 82.2% | 1.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Antigua and Barbuda or South Africa?
- Antigua and Barbuda, at 82.0% against 82.0% in South Africa as of 2024.
- What is the difference in immunization, measles second dose between Antigua and Barbuda and South Africa?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and South Africa?
- 20 years are reported by both, from 2005 to 2024.
- How do Antigua and Barbuda and South Africa rank globally for immunization, measles second dose?
- Antigua and Barbuda ranks 98th and South Africa ranks 98th of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.